1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1092942-82-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-15463S
    Imatinib D8

    STI571 D8; CGP-57148B D8

    Bcr-Abl PDGFR c-Kit Autophagy Cancer
    Imatinib D8 (STI571 D8) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.